Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pfizer sees $10-$15 billion in annual mRNA vaccine revenue by 2030
The company provided potential revenue details from vaccines across its portfolio, including its already-approved COVID-19 vaccine…
Australia’s CSL names insider Paul McKenzie as CEO
CSL makes most of its money paying people in the United States (US) for blood plasma, which it uses for treatments of rare…
SCOPE, Indore organises ‘Academia-Industry Summit 2022’ in association with FOPE
During the summit, SCOPE signed around 22 Memorandums of Understanding (MoUs) with different industries
Cancer drugmaker Clovis files for bankruptcy, hit by falling sales
Clovis has been struggling to sell its cancer drug Rubraca, the company's only approved drug, as sales were hit in recent years by…
Roche presents new data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022
Updated data from phase-III Polarix study continue to demonstrate a statistically significant reduction in the risk of disease…
Signet organises joint-technical seminar in collaboration with IFF and Meggle
The seminars were held in Mumbai and Hyderabad
An overview of IPR in pharma industry: How have its implications changed post-pandemic?
Management of IP and IPR is a multi-dimensional task and calls for many different actions and strategies which need to be aligned…
US FDA gives final approval to Zydus’s two capsules
While Silodosin capsules are indicated to treat signs and symptoms of an enlarged prostate gland, Pregabalin capsules are…
PM Modi inaugurates three national AYUSH institutes
The institutes are All India Institute of Ayurveda in Goa, National Institute of Unani Medicine in Ghaziabad and National…
Lupin launches generic joint pain drug in US
The company's product -- Diclofenac Sodium Topical Solution 2% -- is the generic version of Horizon Pharma Therapeutics Pennsaid